223 related articles for article (PubMed ID: 7665661)
21. Isolation of Borrelia burgdorferi from saliva of the tick vector, Ixodes scapularis.
Ewing C; Scorpio A; Nelson DR; Mather TN
J Clin Microbiol; 1994 Mar; 32(3):755-8. PubMed ID: 8195390
[TBL] [Abstract][Full Text] [Related]
22. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi.
Fikrig E; Telford SR; Wallich R; Chen M; Lobet Y; Matuschka FR; Kimsey RB; Kantor FS; Barthold SW; Spielman A; Flavell RA
J Exp Med; 1995 Jan; 181(1):215-21. PubMed ID: 7807004
[TBL] [Abstract][Full Text] [Related]
23. Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii.
Gern L; Hu CM; Voet P; Hauser P; Lobet Y
Vaccine; 1997 Oct; 15(14):1551-7. PubMed ID: 9330467
[TBL] [Abstract][Full Text] [Related]
24. OspA antibodies inhibit the acquisition of Borrelia burgdorferi by Ixodes ticks.
de Silva AM; Fish D; Burkot TR; Zhang Y; Fikrig E
Infect Immun; 1997 Aug; 65(8):3146-50. PubMed ID: 9234767
[TBL] [Abstract][Full Text] [Related]
25. Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A.
Golde WT; Kappel KJ; Dequesne G; Feron C; Plainchamp D; Capiau C; Lobet Y
Infect Immun; 1994 Jun; 62(6):2625-7. PubMed ID: 8188388
[TBL] [Abstract][Full Text] [Related]
26. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.
Fikrig E; Telford SR; Barthold SW; Kantor FS; Spielman A; Flavell RA
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5418-21. PubMed ID: 1608951
[TBL] [Abstract][Full Text] [Related]
27. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development.
Wilske B; Busch U; Fingerle V; Jauris-Heipke S; Preac Mursic V; Rössler D; Will G
Infection; 1996; 24(2):208-12. PubMed ID: 8740124
[TBL] [Abstract][Full Text] [Related]
28. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Borrelia burgdorferi sensu lato strains isolated from Ixodes ricinus in Mecklenburg-Vorpommern, Germany.
Lottmann H; Wilske B; Herrmann H
Med Microbiol Immunol; 1996 Feb; 184(4):181-4. PubMed ID: 8811650
[TBL] [Abstract][Full Text] [Related]
30. Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi.
Gilmore RD; Bacon RM; Carpio AM; Piesman J; Dolan MC; Mbow ML
J Med Microbiol; 2003 Jul; 52(Pt 7):551-556. PubMed ID: 12808075
[TBL] [Abstract][Full Text] [Related]
31. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
Aydintug MK; Gu Y; Philipp MT
Infect Immun; 1994 Nov; 62(11):4929-37. PubMed ID: 7927774
[TBL] [Abstract][Full Text] [Related]
32. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.
Ohnishi J; Piesman J; de Silva AM
Proc Natl Acad Sci U S A; 2001 Jan; 98(2):670-5. PubMed ID: 11209063
[TBL] [Abstract][Full Text] [Related]
33. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.
Zhong W; Gern L; Stehle T; Museteanu C; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1999 Mar; 29(3):946-57. PubMed ID: 10092099
[TBL] [Abstract][Full Text] [Related]
34. Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks.
Gipson CL; de Silva AM
Infect Immun; 2005 Mar; 73(3):1644-7. PubMed ID: 15731064
[TBL] [Abstract][Full Text] [Related]
35. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
Chang YF; Appel MJ; Jacobson RH; Shin SJ; Harpending P; Straubinger R; Patrican LA; Mohammed H; Summers BA
Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289
[TBL] [Abstract][Full Text] [Related]
36. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies.
Kurtenbach K; Dizij A; Voet P; Hauser P; Simon MM
Vaccine; 1997 Oct; 15(15):1670-4. PubMed ID: 9364698
[TBL] [Abstract][Full Text] [Related]
37. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms.
Roehrig JT; Piesman J; Hunt AR; Keen MG; Happ CM; Johnson BJ
J Immunol; 1992 Dec; 149(11):3648-53. PubMed ID: 1431134
[TBL] [Abstract][Full Text] [Related]
38. Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae).
Kurtenbach K; Dizij A; Seitz HM; Margos G; Moter SE; Kramer MD; Wallich R; Schaible UE; Simon MM
Infect Immun; 1994 Dec; 62(12):5344-52. PubMed ID: 7960113
[TBL] [Abstract][Full Text] [Related]
39. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector.
Battisti JM; Bono JL; Rosa PA; Schrumpf ME; Schwan TG; Policastro PF
Infect Immun; 2008 Nov; 76(11):5228-37. PubMed ID: 18779341
[TBL] [Abstract][Full Text] [Related]
40. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A.
Pal U; de Silva AM; Montgomery RR; Fish D; Anguita J; Anderson JF; Lobet Y; Fikrig E
J Clin Invest; 2000 Aug; 106(4):561-9. PubMed ID: 10953031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
